{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T07:20:33Z","timestamp":1648538433290},"reference-count":26,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.3892\/ol.2016.5165","type":"journal-article","created":{"date-parts":[[2016,9,21]],"date-time":"2016-09-21T05:03:35Z","timestamp":1474434215000},"page":"4245-4251","source":"Crossref","is-referenced-by-count":0,"title":["Routine blood examinations combined with morphological analysis for the diagnosis of myelodysplastic\/myeloproliferative neoplasms"],"prefix":"10.3892","volume":"12","author":[{"given":"Huanling","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangli","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuantang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,9,21]]},"reference":[{"key":"key20180108110855_b1-ol-0-0-5165","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"issue":"Suppl 1","key":"key20180108110855_b2-ol-0-0-5165","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1111\/ijlh.12509","article-title":"Myeloproliferative neoplasms (BCR-ABL1 negative) and myelodysplastic\/myeloproliferative neoplasms: Current diagnostic principles and upcoming updates","volume":"38","author":"Geyer","year":"2016","journal-title":"Int J Lab Hematol"},{"key":"key20180108110855_b3-ol-0-0-5165","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/leu.2008.119","article-title":"The myelodysplastic\/myeloproliferative neoplasms: Myeloproliferative diseases with dysplastic features","volume":"22","author":"Orazi","year":"2008","journal-title":"Leukemia"},{"key":"key20180108110855_b4-ol-0-0-5165","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3324\/haematol.2014.114660","article-title":"An International MDS\/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic\/myeloproliferative neoplasms","volume":"100","author":"Mughal","year":"2015","journal-title":"Haematologica"},{"key":"key20180108110855_b5-ol-0-0-5165","first-page":"55","article-title":"Recommended methods for cytological procedures in haematology","volume":"7","author":"Shibata","year":"1985","journal-title":"International Committee for Standardization in Haematology (ICSH). Clin Lab Haematol"},{"key":"key20180108110855_b6-ol-0-0-5165","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3892\/etm.2013.975","article-title":"Characteristics of the four subtypes of myelodysplastic\/myeloproliferative neoplasms","volume":"5","author":"Wu","year":"2013","journal-title":"Exp Ther Med"},{"key":"key20180108110855_b7-ol-0-0-5165","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1080\/10428190701216386","article-title":"Prognostic factors and risk assessment in chronic myelomonocytic leukemia: Validation study of the M.D","volume":"48","author":"Beran","year":"2007","journal-title":"Anderson Prognostic Scoring System. Leuk Lymphoma"},{"key":"key20180108110855_b8-ol-0-0-5165","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3324\/haematol.11051","article-title":"Chronic myelomonocytic leukemia in the light of the WHO proposals","volume":"92","author":"Germing","year":"2007","journal-title":"Haematologica"},{"key":"key20180108110855_b9-ol-0-0-5165","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/ajh.23203","article-title":"Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management","volume":"87","author":"Parikh","year":"2012","journal-title":"Am J Hematol"},{"key":"key20180108110855_b10-ol-0-0-5165","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.critrevonc.2015.03.002","article-title":"Chronic myelomonocytic leukemia: Forefront of the field in 2015","volume":"95","author":"Benton","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20180108110855_b11-ol-0-0-5165","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1111\/j.1751-553X.2011.01351.x","article-title":"Clinical course and molecular features in 21 patients with atypical chronic myeloid leukemia","volume":"34","author":"Koldehoff","year":"2012","journal-title":"Int J Lab Hematol"},{"key":"key20180108110855_b12-ol-0-0-5165","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"key20180108110855_b13-ol-0-0-5165","first-page":"1566","article-title":"Identification of risk factors in atypical chronic myeloid leukemia","volume":"91","author":"Breccia","year":"2006","journal-title":"Haematologica"},{"key":"key20180108110855_b14-ol-0-0-5165","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1600-0609.2009.01283.x","article-title":"The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia","volume":"83","author":"Xubo","year":"2009","journal-title":"Eur J Haematol"},{"key":"key20180108110855_b15-ol-0-0-5165","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood-2014-02-553800","article-title":"Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic\/myeloproliferative neoplasms","volume":"123","author":"Wang","year":"2014","journal-title":"Blood"},{"key":"key20180108110855_b16-ol-0-0-5165","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/cncr.10832","article-title":"Characteristics and outcome of patients with Philadelphia chromosome negative, bcr\/abl negative chronic myelogenous leukemia","volume":"95","author":"Onida","year":"2002","journal-title":"Cancer"},{"key":"key20180108110855_b17-ol-0-0-5165","first-page":"173","article-title":"Peculiarities in the Diagnosis Approach of MDS\/MPN-U Patients","volume":"7","author":"Triantafyllidis","year":"2012","journal-title":"Maedica (Buchar)"},{"key":"key20180108110855_b18-ol-0-0-5165","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00277-013-1915-x","article-title":"Clinical significance of SF3B1 mutations in Korean patients with myelodysplastic syndromes and myelodysplasia\/myeloproliferative neoplasms with ring sideroblasts","volume":"93","author":"Seo","year":"2014","journal-title":"Ann Hematol"},{"key":"key20180108110855_b19-ol-0-0-5165","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/leu.2014.8","article-title":"Myelodysplastic\/myeloproliferative neoplasms, unclassifiable (MDS\/MPN, U): Natural history and clinical outcome by treatment strategy","volume":"28","author":"DiNardo","year":"2014","journal-title":"Leukemia"},{"key":"key20180108110855_b20-ol-0-0-5165","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1053\/j.semdp.2011.07.002","article-title":"Myelodysplastic\/myeloproliferative neoplasms","volume":"28","author":"Hyjek","year":"2011","journal-title":"Semin Diagn Pathol"},{"key":"key20180108110855_b21-ol-0-0-5165","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3324\/haematol.2008.005421","article-title":"International Working Group on Morphology of Myelodysplastic Syndrome: Morphological evaluation of monocytes and their precursors","volume":"94","author":"Goasguen","year":"2009","journal-title":"Haematologica"},{"key":"key20180108110855_b22-ol-0-0-5165","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1751-553X.2010.01251.x","article-title":"Diagnosing myelodysplastic\/myeloproliferative neoplasms: Laboratory testing strategies to exclude other disorders","volume":"32","author":"Hall","year":"2010","journal-title":"Int J Lab Hematol"},{"key":"key20180108110855_b23-ol-0-0-5165","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00000478-200405000-00004","article-title":"Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes\/interferon-producing cells associated with myeloid disorders","volume":"28","author":"Vermi","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"key20180108110855_b24-ol-0-0-5165","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MOH.0000000000000021","article-title":"Making sense of the myelodysplastic\/myeloproliferative neoplasms overlap syndromes","volume":"21","author":"Tiu","year":"2014","journal-title":"Curr Opin Hematol"},{"key":"key20180108110855_b25-ol-0-0-5165","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1182\/asheducation-2011.1.264","article-title":"Myelodysplastic\/myeloproliferative neoplasms","volume":"2011","author":"Cazzola","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"key20180108110855_b26-ol-0-0-5165","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/cyto.b.21068","article-title":"Multiparameter flow cytometry reveals myelodysplasia-related aberrant antigen expression in myelodysplastic\/myeloproliferative neoplasms","volume":"84","author":"Kern","year":"2013","journal-title":"Cytometry B Clin Cytom"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2016.5165\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T16:49:45Z","timestamp":1568393385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2016.5165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,21]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,9,21]]},"published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.3892\/ol.2016.5165"],"URL":"https:\/\/doi.org\/10.3892\/ol.2016.5165","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,21]]}}}